Evidence map›Paper›PMID 28509605›Full record

Trial reportHuman vaccines & immunotherapeutics2017

Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.

Anand Prakash Dubey, Mohammad Moonis Akbar Faridi, Monjori Mitra, Iqbal Rajinder Kaur, Aashima Dabas, Jaydeep Choudhury, Mallar Mukherjee, Devendra Mishra

Open access · bronzeAbstract readClinical Trial, Phase IIClinical Trial, Phase IIIComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Human vaccines & immunotherapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anand Prakash Dubeya Department of Pediatrics , Maulana Azad Medical College , New Delhi , India.
Mohammad Moonis Akbar Faridib University College of Medical Sciences , Delhi , India.
Monjori Mitrac Institute of Child Health , Kolkata , India.
Iqbal Rajinder Kaurd Department of Microbiology University College of Medical Sciences , Delhi , India.
Aashima Dabasa Department of Pediatrics , Maulana Azad Medical College , New Delhi , India.
Jaydeep Choudhuryc Institute of Child Health , Kolkata , India.
Mallar Mukherjeec Institute of Child Health , Kolkata , India.
Devendra Mishraa Department of Pediatrics , Maulana Azad Medical College , New Delhi , India.
Institute of Child Health · INMaulana Azad Medical College · INUniversity College of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Varicella or chickenpox is a highly contagious disease with a high secondary attack rate. Almost 30% of Indian adolescents lack protective antibodies against varicella, emphasizing the need of routine varicella immunization. The Oka VZV is a well-established, safe and efficacious vaccine strain that is highly immunogenic and produces lifelong protective immunity. The present multicentric, open label, randomized, controlled Phase II/III study, compared the Bio Pox™ (indigenous investigational vaccine) with a licensed vaccine, Varivax™

Indexed as

Immunogenicity, VaccineAdolescentAntibodies, ViralChickenpoxChickenpox VaccineChildChild, PreschoolEnzyme-Linked Immunosorbent AssayFemaleHumansImmunization ScheduleIndiaMaleVaccinationAntibodies, ViralChickenpox VaccinechickenpoxGlycoprotein Enzyme Linked Immunoassay (Gp ELISA)immunogenicitysafetyseroconversionVaricella

Identifiers

PMID28509605
PMCPMC5612528
OpenAlexW2615435404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.